Friday, February 7, 2025

NVIDIA & IQVIA Develop Advanced Healthcare, Life Sciences AI

NVIDIA and IQVIA Develop Domain-Expert Agentic AI for Life Sciences and Healthcare.

The top clinical research and commercial services provider in the world, NVIDIA AI Foundry, will make AI agents available to its worldwide life sciences clients to assist speed up intricate processes in evidence management, medication research and development, and commercialization.

In order to speed up research, clinical development, and access to innovative medications, IQVIA, the top provider of clinical research services, commercial analytics, and healthcare intelligence worldwide, is collaborating with NVIDIA to create unique foundation models and agentic AI processes.

The industry will benefit from AI applications trained on the organization’s extensive healthcare-specific data and directed by its profound domain experience. These applications will increase the effectiveness of clinical trials and optimise planning for the introduction of treatments and medical equipment, ultimately leading to better patient outcomes.

With operations in more than 100 nations, IQVIA has established the largest healthcare network in the world and is uniquely integrated into the ecosystem using the most extensive and detailed collection of data, analytics, and technology available.

The collection of models, AI agents, and reference workflows will be developed using the NVIDIA AI Foundry platform for creating custom models, as announced today at the J.P. Morgan Conference in San Francisco. This will enable it thousands of pharmaceutical, biotech, and medical device customers to take advantage of NVIDIA’s agentic AI capabilities as well as IQVIA’s technologies, life sciences data, and expertise.

Facilitating Clinical Trials for Industry Applications

With 30% of global data volume, the healthcare and life sciences sector produces more information than any other industry.

In order to create linguistic and multimodal foundational models that will drive a range of specialized IQVIA AI agents, IQVIA intends to leverage its unmatched information assets, analytics, and domain expertise known as IQVIA Connected Intelligence with the NVIDIA AI Foundry service.

It is expected that these agents will be available in pre-established processes, or blueprints, that will complete a certain activity. The goal of this collaboration is to quicken the IQVIA Healthcare-grade AI innovation cycle. By making sure that its AI-powered capabilities are based on patient safety, privacy, and regulatory compliance, IQVIA has been at the forefront of the responsible use of AI. IQVIA Healthcare-grade AI is a testament to the company’s dedication to these values.

Clinical development, where clinical trials are carried out for novel medications, is one important area of possibility. There are numerous workflows in each trial that may be supported by AI agents, and the entire procedure takes an average of 11 years. A clinical trial’s first phases, for instance, include participant recruitment, site selection, regulatory submissions, and close coordination between study sites and their sponsors.

NVIDIA AI Foundry Simplifies the Creation of Custom Models

The tools in NVIDIA AI Foundry and the NVIDIA AI Enterprise software platform, such as NVIDIA NIM microservices, particularly the Llama Nemotron and Cosmos Nemotron model families; NVIDIA AI Blueprint reference workflows; the NVIDIA NeMo platform for creating custom generative AI; and dedicated capacity on NVIDIA DGX Cloud, are being used by IQVIA to expedite the development of these AI agents.

In order to train AI models and agents for domain specific and even customer-specific applications, IQVIA can use the NVIDIA AI Blueprint for multimodal PDF data extraction to unlock the vast amount of healthcare text, graphs, charts, and tables stored in PDF files. Knowledge graph building is then accelerated using NVIDIA RAPIDS data science libraries.

More AI agents might automate time consuming, complicated processes like patient recruiting and document preparation, freeing up healthcare workers to concentrate on interpersonal communication and strategic decision making.

IQVIA

NVIDIA and IQVIA are collaborating to speed up healthcare-grade AI.

Customers will be able to speed up their efforts to enhance patient outcomes in new ways due to the partnership.

IQVIA Distinction

Increasing the rate of innovation

From utilising new technologies to coming up with more efficient ways to work, IQVIA aim to be creative in everything to do.

Intelligence that is connected

Connecting the appropriate technology, insights, and stakeholders in an intelligent manner is the first step towards improving patient outcomes and advancing health.

Making the planet healthy

This are dedicated to advancing healthcare technologies that enhance the health of people and populations worldwide, working in tandem with the clients and partners.

Drakshi
Drakshi
Since June 2023, Drakshi has been writing articles of Artificial Intelligence for govindhtech. She was a postgraduate in business administration. She was an enthusiast of Artificial Intelligence.
RELATED ARTICLES

Recent Posts

Popular Post

Govindhtech.com Would you like to receive notifications on latest updates? No Yes